Literature DB >> 10593955

Single amino acid substitutions in alpha-conotoxin PnIA shift selectivity for subtypes of the mammalian neuronal nicotinic acetylcholine receptor.

R C Hogg1, L P Miranda, D J Craik, R J Lewis, P F Alewood, D J Adams.   

Abstract

The alpha-conotoxins, a class of nicotinic acetylcholine receptor (nAChR) antagonists, are emerging as important probes of the role played by different nAChR subtypes in cell function and communication. In this study, the native alpha-conotoxins PnIA and PnIB were found to cause concentration-dependent inhibition of the ACh-induced current in all rat parasympathetic neurons examined, with IC(50) values of 14 and 33 nM, and a maximal reduction in current amplitude of 87% and 71%, respectively. The modified alpha-conotoxin [N11S]PnIA reduced the ACh-induced current with an IC(50) value of 375 nM and a maximally effective concentration caused 91% block. [A10L]PnIA was the most potent inhibitor, reducing the ACh-induced current in approximately 80% of neurons, with an IC(50) value of 1.4 nM and 46% maximal block of the total current. The residual current was not inhibited further by alpha-bungarotoxin, but was further reduced by the alpha-conotoxins PnIA or PnIB, and by mecamylamine. (1)H NMR studies indicate that PnIA, PnIB, and the analogues, [A10L]PnIA and [N11S]PnIA, have identical backbone structures. We propose that positions 10 and 11 of PnIA and PnIB influence potency and determine selectivity among alpha7 and other nAChR subtypes, including alpha3beta2 and alpha3beta4. Four distinct components of the nicotinic ACh-induced current in mammalian parasympathetic neurons have been dissected with these conopeptides.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10593955     DOI: 10.1074/jbc.274.51.36559

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Rational design of alpha-conotoxin analogues targeting alpha7 nicotinic acetylcholine receptors: improved antagonistic activity by incorporation of proline derivatives.

Authors:  Christopher Armishaw; Anders A Jensen; Thomas Balle; Richard J Clark; Kasper Harpsøe; Christian Skonberg; Tommy Liljefors; Kristian Strømgaard
Journal:  J Biol Chem       Date:  2009-01-08       Impact factor: 5.157

2.  alpha4/7-conotoxin Lp1.1 is a novel antagonist of neuronal nicotinic acetylcholine receptors.

Authors:  Can Peng; Yuhong Han; Tanya Sanders; Geoffrey Chew; Jing Liu; Edward Hawrot; Chengwu Chi; Chunguang Wang
Journal:  Peptides       Date:  2008-06-07       Impact factor: 3.750

Review 3.  α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition.

Authors:  Hartmut Cuny; Rilei Yu; Han-Shen Tae; Shiva N Kompella; David J Adams
Journal:  Br J Pharmacol       Date:  2017-06-11       Impact factor: 8.739

4.  α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.

Authors:  Arik J Hone; Mick'l Scadden; Joanna Gajewiak; Sean Christensen; Jon Lindstrom; J Michael McIntosh
Journal:  Mol Pharmacol       Date:  2012-08-22       Impact factor: 4.436

5.  Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors.

Authors:  Todd T Talley; Baldomero M Olivera; Kyou-Hoon Han; Sean B Christensen; Cheryl Dowell; Igor Tsigelny; Kwok-Yiu Ho; Palmer Taylor; J Michael McIntosh
Journal:  J Biol Chem       Date:  2006-06-27       Impact factor: 5.157

6.  Atypical alpha-conotoxin LtIA from Conus litteratus targets a novel microsite of the alpha3beta2 nicotinic receptor.

Authors:  Sulan Luo; Kalyana Bharati Akondi; Dongting Zhangsun; Yong Wu; Xiaopeng Zhu; Yuanyan Hu; Sean Christensen; Cheryl Dowell; Norelle L Daly; David J Craik; Ching-I Anderson Wang; Richard J Lewis; Paul F Alewood; J Michael McIntosh
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

7.  Discovery of peptide ligands through docking and virtual screening at nicotinic acetylcholine receptor homology models.

Authors:  Abba E Leffler; Alexander Kuryatov; Henry A Zebroski; Susan R Powell; Petr Filipenko; Adel K Hussein; Juliette Gorson; Anna Heizmann; Sergey Lyskov; Richard W Tsien; Sébastien F Poget; Annette Nicke; Jon Lindstrom; Bernardo Rudy; Richard Bonneau; Mandë Holford
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

8.  A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors.

Authors:  Sulan Luo; Dongting Zhangsun; Christina I Schroeder; Xiaopeng Zhu; Yuanyan Hu; Yong Wu; Maegan M Weltzin; Spencer Eberhard; Quentin Kaas; David J Craik; J Michael McIntosh; Paul Whiteaker
Journal:  FASEB J       Date:  2014-01-07       Impact factor: 5.191

9.  Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII.

Authors:  Richard J Clark; Harald Fischer; Louise Dempster; Norelle L Daly; K Johan Rosengren; Simon T Nevin; Frederic A Meunier; David J Adams; David J Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-14       Impact factor: 11.205

Review 10.  Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.

Authors:  Layla Azam; J Michael McIntosh
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.